Unsupported browser detected
Your browser appears to be unsupported. Because of this, portions of the site may not function as intended.
Please install a current version of Chrome, Firefox, Edge, or Safari for a better experience.
Purpose
to develop a proof-of-concept in vitro process to produce the antimalarial drug precursor, dihydroartemisinic acid, to allow for production at a reduced cost to meet global demand, especially for developing nations
Grantee
Division
Global Health
Date
JULY 2018
Region served
GLOBAL
Committed amount
$929,600
Grant topic
Development of Solutions to Improve Global Health,
Research and Learning Opportunities
Duration (months)
31
Grantee location
Berkeley, California, United States
More about our work
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.